9 junio 2015
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. A new study sheds light on how GLP-1 receptor agonists alter the brain’s response to food, possibly reducing cravings and increasing satisfaction while eating.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/cXUsmNFCHO0/150609102610.htm
